qFit model

PDB 4B6L|dpdb_v1yqqpzc

qFit model

Discovery of Oral Polo-Like Kinase (PLK) Inhibitors with Enhanced Selectivity Profile using Residue Targeted Drug Design

Program
Phenix 2.0_5824
Model type
Multiconformer
Purpose
Model Building
Atoms
2,557
Residues
281
Protein chains
1
Alternate-location fraction
0.36%
Ligands
9ZP, SO4

Evaluations

R-work
0.216
R-free
0.265
Clashscore
—

Macromolecules

The same in every model of this entry.

Entity 1
MoleculeChainsLengthOrganismUniProtDetails
SERINE/THREONINE-PROTEIN KINASE PLK3281
  • ConstructCATALYTIC KINASE DOMAIN, RESIDUES 52-332

Data

L0 Raw
L1 Processed
L2 Models
L3 Evaluations